BioSniper
Patent Expiry

Patent/Exclusivity Expiry: BREO ELLIPTA

October 11, 2030
Company
BRIGHT MINDS BIOSCIENCES INC. (DRUG)
Drug
BREO ELLIPTA

Other upcoming events for DRUG

Patent ExpiryPatent/Exclusivity Expiry: DUEXIS
Jul 18, 2026
Patent ExpiryPatent/Exclusivity Expiry: FLUTICASONE PROPIONATE
Sep 20, 2026
Patent ExpiryPatent/Exclusivity Expiry: ADVIL ALLERGY SINUS
Feb 28, 2027
Patent ExpiryPatent/Exclusivity Expiry: FLONASE SENSIMIST ALLERGY RELIEF
Oct 15, 2028
Patent ExpiryPatent/Exclusivity Expiry: TRELEGY ELLIPTA
Nov 29, 2030

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
DRUG OverviewPDUFA DatesPhase 3 Readouts
BioSniper

AI-Powered Biotech Data Intelligence Platform

Product

  • Pricing
  • FAQ

Resources

  • Event Calendar
  • PDUFA Calendar
  • AdCom Schedule
  • Blog
  • About

Data & Tools

  • Cash Runway Calculator
  • Trial Success Rates
  • FDA Review Timelines
  • PDUFA Complete Guide
  • Reading FDA AdCom Results

Legal

  • Privacy Policy
  • Terms of Service
  • Refund Policy
  • Contact Us

BioSniper is a data analytics SaaS tool for research purposes only. It does not constitute professional advice of any kind. Users should independently verify data and make their own decisions.

© 2026 Biosniper All rights reserved.Payments powered by Paddle